Degradation of breast cancer matrix is mainly dependent on the regulation of lysyl oxidase (LOX), lysyl oxidase like-1-4 (LOXL 1-4), and matrix metalloproteinases (MMPs), which are extracellular matrix remodeling enzymes (23, 24). The gene discussed is LOX; the disease is breast carcinoma.